Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
作者信息
Friedhoff A J, Rosengarten H, Bonnet K
出版信息
Psychopharmacol Bull. 1978 Oct;14(4):77-9.
PMID:704769
Abstract
摘要
相似文献
1
Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
Psychopharmacol Bull. 1978 Oct;14(4):77-9.
2
Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
Adv Neurol. 1983;37:259-66.
3
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.严重帕金森症与迟发性运动障碍并存作为抗精神病药物治疗的副作用。
J Clin Psychiatry. 1984 Jan;45(1):28-30.
4
Dopamine agonists in clinical research for new tardive dyskinesia treatments.用于新型迟发性运动障碍治疗的多巴胺激动剂的临床研究
Mod Probl Pharmacopsychiatry. 1983;21:97-110. doi: 10.1159/000408487.
5
6
Animal models of tardive dyskinesia: their use in the search for new treatment methods.
Mod Probl Pharmacopsychiatry. 1983;21:5-20. doi: 10.1159/000408479.
7
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Pharmakopsychiatr Neuropsychopharmakol. 1978 Nov;11(6):294-8. doi: 10.1055/s-0028-1094589.
8
Animal models of tardive dyskinesia--a review.迟发性运动障碍的动物模型——综述
Indian J Physiol Pharmacol. 2001 Apr;45(2):148-60.
9
Double-blind carbidopa/levodopa and placebo study in tardive dyskinesia.卡比多巴/左旋多巴与安慰剂双盲对照治疗迟发性运动障碍的研究。
J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):49S-51S.
10
Drug therapy for Parkinsonism.帕金森病的药物治疗
Mod Healthc (Short Term Care). 1976 Jan;5(1):62.
引用本文的文献
1
Abnormal involuntary movements: side-effect of neuroleptic drugs.异常不自主运动：神经安定药物的副作用。
Can Fam Physician. 1982 Jan;28:105-9.
Zotero 插件